The STING pathway is indispensable in tumor treatment, as activation of STING has a synergizing effect on therapy in pancreatic cancer, whereas knockdown of STING or cGAS signaling is sufficient to abolish the efficacy of immune checkpoint inhibitors [32, 33]. The gene discussed is STING1; the disease is neoplasm.